Hospitals and other healthcare firms are feeling more confident about their economic stability, according to a recent survey from GE Capital. The survey, which focused on c-suite executive as mid market companies ranging from $10 million to $1 billion in assets, found that “healthcare firms continue to enjoy improving financial performance and increasing employment.” Much […]
University of Michigan spinout Tangent Medical has raised a $5 million senior secured term loan credit facility from GE Capital, Healthcare Financial Services to commercialize its IV stabilization tech abroad. While company Vice President of Sales and Marketing Curtis Bloch said the funding will be used for a variety of commercialization efforts, a significant portion would be used […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
With the generic cliff receding, R&D pipelines continuing to improve and FDA approvals of biopharmaceuticals up, opportunities outweigh the risks for investors in the biopharmaceuticals industry. The key for the industry going forward will be to continue to improve R&D productivity and commercialize drugs that represent a true advance to current treatment.
Healthcare IT can improve the quality of care by capturing data or identifying drug interactions, but the HIT industry has its challenges. Healthcare reform is affecting how people invest in the HIT industry, but the outlook for this industry remains bright.
The following post is sponsored by GE Capital Healthcare Financial Services. Against a backdrop of slowing healthcare expenditures and ongoing implementation of the Affordable Care Act (ACA), the dynamics of the U.S. medical device industry have become increasingly fluid. In this article, Elliot Hyun, a medical device analyst at GE Capital Healthcare Financial Services, discusses […]